RESUMEN
As typical nano metarials in near infrared waveband, PbSe Quantum Dots have a very large exciton Bohr radius of 46 nm and a small band gap of 0.28 eV at room temperature. PbSe QDs have very unique properties, such as the quantum confined optical property, and which possess high photoluminescence (PL) quantum yield (QY) with size dependent tunable wavelength emissions. By analyzing the luminescence spectrum of PbSe Quantum Dots, a method through adjusting the particle size of PbSe Quantum Dots (QDs) to match gas absorption spectrum was presented in this paper. 4.6 and 6.1 nm PbSe QDs were synthesized and deposited on the GaN chip to fabricate the NIR QDs light sources. The PbSe QDs-UV glue composites thickness was determined to be 48.0 and 671.5 µm for 6.1 and 4.6 nm PbSe QDs. The NIR QDs were used to detect the C2H2 and NH3 gas. The experiments show that the PL spectrum of 4.6 nm NIR QDs can cover the entire absorption spectrum of C2H2 gas (from 1 500 to 1 550 nm) and the PL spectrum of 6.1 nm NIR QDs can cover the entire absorption spectrum of NH3 gas (from 1 900 to 2 060 nm). By changing the quantum size of QDs, the PL peak of the NIR QDS light source can be adjusted to cover the absorption peak of different gases. The matching method presented in this paper is efficient and feasible, which has great application potential in gas detection.
RESUMEN
OBJECTIVE: To determine the expression of Bcl2 related protein A1(Bfl-1) mRNA in prostate cancer cell lines and tissues, and to explore the functions of Bfl-1 in prostate adenocarcinoma. METHODS: RT-PCR, real-time quantitative PCR (Q-PCR)and in situ hybridization (ISH) were used to detect the expression of Bfl-1 mRNA in prostate cancer cell lines, tissues and benign prostate hyperplasia (BPH) tissue samples. The relationship between Bfl-1 expression and clinicopathological parameters was analyzed. Antisense oligonucleotides (ASONs) were used to interfere the expression of Bfl-1 and its effects on prostate cancer cells. MTT was used to detect the survival, morphologic changes of prostate cancer cells was observed by inverted microscope. RESULTS: Bfl-1 mRNA, detected by RT-PCR, Q-PCR and ISH, was overexpressed in the androgen-independent prostate cancer cell lines PC-3 and DU145, but not detectable in the androgen-dependent prostate cancer cell line LNCaP and BPH tissue samples (P < 0.05). Significantly higher Bfl-1 mRNA levels were observed in higher stage and metastatic prostate cancer cases than those without metastasis or of low stage. ASONs targeting Bfl-1 significantly inhibited androgen-independent prostate cancer cell growth (P < 0.05), cell was rounding off or fragmentation. CONCLUSION: Bfl-1 is involved in maintaining the hormone-independent prostate cancer cell growth. Bfl-1 may become a new therapeutic target in advanced prostate cancer.
Asunto(s)
Apoptosis , Hiperplasia Prostática/metabolismo , Neoplasias de la Próstata/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Línea Celular , Transformación Celular Neoplásica , Humanos , Hibridación in Situ , Masculino , Antígenos de Histocompatibilidad Menor , Oligonucleótidos Antisentido , ARN MensajeroRESUMEN
OBJECTIVE: To explore the mechanism and the compensation proceeding of thyroid hyperplasia caused by PTU. METHODS: PTU was administered to rats by gavage at a dose of 5.0 mg/kg B. W for 3, 6, 9, 12, 15, 18, 21 days respectively. All animals were sacrificed after the last dosage, and the expression of TPO and Tg in thyroid was detected by RT-PCR. The serum thyroid hormones were measured by chemoluminescence. RESULTS: Compared with the control group, the TPO mRNA levels of PTU groups were increased, while the Tg mRNA levels were decreased significantly. Serum TT3, TT4 in rats treated with PTU demonstrated a descending trend, while serum TSH showed an ascending trend, and the significant differences were observed after 6 days treating with PTU. CONCLUSION: The interference of PTU on thyroid may relate to inhibiton of Tg gene transcription. The enhancement of TPO gene transcription can't compensate the thyroid function sufficiently.
Asunto(s)
Disruptores Endocrinos/toxicidad , Yoduro Peroxidasa/metabolismo , Propiltiouracilo/toxicidad , Tiroglobulina/metabolismo , Glándula Tiroides/metabolismo , Animales , Hiperplasia/inducido químicamente , Yoduro Peroxidasa/genética , Masculino , ARN Mensajero/genética , ARN Mensajero/metabolismo , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Tiroglobulina/genética , Glándula Tiroides/patologíaRESUMEN
OBJECTIVE: To study the expression rule of proliferating cell nuclear antigen (PCNA) in thyroid when the hyperplasia of male rat thyroid is induced by propylthiouracil (PTU). METHODS: PTU was administered to rats by gavage at a dose of 5.0 mg/kg B. W for 0,3,6,9 and 12 days respectively. All animals were sacrificed after the last dosage, and the expression of PCNA in thyroid was detected by immunohistochemistry and RT-PCR. RESULTS: Compared with the control group, the PCNA level in the thyroid of rats given PTU for 3 days significantly increased (P < 0.05),and reached the highest expression when it was 6 days, but then when it was 9 days and 12 days, the PCNA expression showed a descending tendency. CONCLUSION: PCNA has a expression rule in hyperplastic thyroid: expression increase first but then decrease. This rule confirms the histological change of thyroid in earlier stage. The experimental time of assessment test to thyroid hormone disruptors will be shortened to six days.
Asunto(s)
Antitiroideos/efectos adversos , Antígeno Nuclear de Célula en Proliferación/metabolismo , Propiltiouracilo/efectos adversos , Glándula Tiroides/patología , Animales , Hiperplasia/metabolismo , Masculino , RatasRESUMEN
As a traditional Chinese medicine, Danggui Shaoyao powder has been studied for more than one thousand years. This article reviews the recent advances in chemical constituents, pharmacological activities and clinical application.